Eosinophils in health and disease: The LIAR hypothesis

Clinical and Experimental Allergy

Volumn 40, Issue 4, 2010, Pages 563-575

  Lee, J J ^a   Jacobsen, E A ^a   McGarry, M P ^a   Schleimer, R P ^b   Lee, N A ^a  

^a MAYO GRADUATE SCHOOL   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEPOLIZUMAB; PROTEIN;

ALLERGIC DISEASE; ASTHMA; EFFECTOR CELL; EOSINOPHIL; GASTROINTESTINAL TRACT; HELMINTH; HELMINTHIASIS; HOMEOSTASIS; HOST RESISTANCE; HUMAN; IMMUNITY; IMMUNOCOMPETENT CELL; INFLAMMATION; MORTALITY; NONHUMAN; NOTE; ORGAN TRANSPLANTATION; PARASITOSIS; PATHOLOGY; PRIORITY JOURNAL; SOLID TUMOR; STEM CELL; THYMUS; UTERUS;

ANIMALS; ASTHMA; CYTOTOXICITY, IMMUNOLOGIC; EOSINOPHILS; HELMINTHIASIS; HEMATOPOIESIS; HUMANS; MICE; NEOPLASMS;

EID: 77949349992     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2010.03484.x     Document Type: Note

References (82)

1. Austen KF. Homeostasis of effector systems which can also be recruited for immunologic reactions. [Review]. J Immunol 1978; 121:793-805.
2. Smith H, Cook RM. Immunopharmacology of eosinophils. In: Page CF, ed. The handbook of immunopharmacology, 1st Edn. London: Academic Press, Harcourt Brace Jovanovich, 1993.
3. Taliaferro WH, Sarles MP. The cellular reactions in the skin, lungs, and intestine of normal and immune rats after infection with Nippostrongylus muris. J Infect Dis 1939; 64:157-92.
4. Klion AD, Nutman TB. The role of eosinophils in host defense against helminth parasites. J Allergy Clin Immunol 2004; 113:30-7.
5. Bruschi F, Korenaga M, Watanabe N. Eosinophils and Trichinella infection: toxic for the parasite and the host? Trends Parasitol 2008; 24:462-7.
6. Calhoun WJ, Sedgwick J, Busse WW. The role of eosinophils in the pathophysiology of asthma. Ann N Y Acad Sci 1991; 629:62-72.
7. Bousquet J, Chanez P, Lacoste JY et al. Eosinophilic inflammation in asthma [see comments]. N Engl J Med 1990; 323:1033-9.
8. Gleich GJ. Mechanisms of eosinophil-associated inflammation. J Allergy Clin Immunol 2000; 105:651-63.
9. Lee JJ, Dimina D, Macias MP et al. Defining a link with asthma in mice congenitally deficient in eosinophils. Science 2004; 305:1773-6.
10. Humbles AA, Lloyd CM, McMillan SJ et al. A critical role for eosinophils in allergic airways remodeling. Science 2004; 305:1776-9.
11. Swartz JM, Dyer KD, Cheever AW et al. Schistosoma mansoni infection in eosinophil lineage-ablated mice. Blood 2006; 108:2420-7.
12. Filley WV, Kephardt GM, Holley LE, Gleich GJ. Identification by immunofluorescence of eosinophil granule major basic protein in lung tissues of patients with bronchial asthma. Lancet 1982; ii:11-6.
13. Nair P, Pizzichini MM, Kjarsgaard M et al. Mepolizumab for prednisone-dependent asthma with sputum eosinophilia. N Engl J Med 2009; 360:985-93.
14. Haldar P, Brightling CE, Hargadon B et al. Mepolizumab and exacerbations of refractory eosinophilic asthma. N Engl J Med 2009; 360:973-84.
15. Frigas E, Loegering DA, Gleich GJ. Cytotoxic effects of the guinea pig eosinophil major basic protein on tracheal epithelium. Lab. Invest. 1980; 42:35-43.
16. Denzler KL, Farmer SC, Crosby JR et al. Eosinophil major basic protein-1 does not contribute to allergen-induced airway pathologies in mouse models of asthma. J Immunol 2000; 165:5509-17.
17. Denzler KL, Borchers MT, Crosby JR et al. Extensive eosinophil degranulation and peroxidase-mediated oxidation of airway proteins do not occur in a mouse ovalbumin-challenge model of pulmonary inflammation. J Immunol 2001; 167:1672-82.
18. Moqbel R, Macdonald AJ, Cromwell O, Kay AB. Release of leukotriene C4 (LTC4) from human eosinophils following adherence to IgE- and IgG-coated schistosomula of schistosoma mansoni. Immunology 1990; 69:435-42.
19. Behm CA, Ovington KS. The role of eosinophils in parasitic helminth infections: insights from genetically modified mice. Parasitol Today 2000; 16:202-9.
20. Sher A, Coffman RL. Regulation of immunity to parasites by T cells and T cell-derived cytokines. Annu Rev Immunol 1992; 10:385-409.
21. Dunn CW, Hejnol A, Matus DQ et al. Broad phylogenomic sampling improves resolution of the animal tree of life. Nature 2008; 452:745-9.
22. Meeusen EN, Balic A. Do eosinophils have a role in the killing of helminth parasites? Parasitol Today 2000; 16:95-101.
23. Limaye AP, Abrams JS, Silver JE, Ottesen EA, Nutman TB. Regulation of parasite-induced eosinophilia: selectively increased interleukin 5 production in helminth-infected patients. J Exp Med 1990; 172:399-402.
24. Takatsu K, Tominaga A, Harada N et al. T cell-replacing factor (TRF)/interleukin 5 (IL-5): molecular and functional properties. [Review]. Immunol Rev 1988; 102:107-35.
25. Clutterbuck E, Shields JG, Gordon J et al. Recombinant human interleukin 5 is an eosinophil differentiation factor but has no activity in standard human B cell growth factor assays. Eur J Immunol 1987; 17:1743-50.
26. Barreda DR, Hanington PC, Belosevic M. Regulation of myeloid development and function by colony stimulating factors. Dev Comp Immunol 2004; 28:509-54.
27. Huber HL, Koessler KK. The pathology of bronchial asthma. Arch Intern Med 1922; 30:689-760.
28. Wenzel SE. Eosinophils in asthma - closing the loop or opening the door? N Engl J Med 2009; 360:1026-8.
29. Gouon-Evans V, Lin EY, Pollard JW. Requirement of macrophages and eosinophils and their cytokines/chemokines for mammary gland development. Breast Cancer Res 2002; 4:155-64.
30. Wehling-Henricks M, Sokolow S, Lee JJ, Myung KH, Villalta SA, Tidball JG. Major basic protein-1 promotes fibrosis of dystrophic muscle and attenuates the cellular immune response in muscular dystrophy. Hum Mol Genet 2008; 17:2280-92.
31. Lotfi R, Lee JJ, Lotze MT. Eosinophilic granulocytes and damage-associated molecular pattern molecules (DAMPs): role in the inflammatory response within tumors. J Immunother 2007; 30:16-28.
32. Gude DR, Alvarez SE, Paugh SW et al. Apoptosis induces expression of sphingosine kinase 1 to release sphingosine-1-phosphate as a "come-and-get-me" signal. FASEB J 2008; 22:2629-38.
33. Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 2009; 324:1029-33.
34. Elsas PX, Elsas MI. Eosinophilopoiesis at the cross-roads of research on development, immunity and drug discovery. Curr Med Chem 2007; 14:1925-39.
35. Stappenbeck TS, Miyoshi H. The role of stromal stem cells in tissue regeneration and wound repair. Science 2009; 324: 1666-9.
36. Uccelli A, Moretta L, Pistoia V. Mesenchymal stem cells in health and disease. Nat Rev Immunol 2008; 8:726-36.
37. Spencer LA, Szela CT, Perez SA et al. Human eosinophils constitutively express multiple Th1, Th2, and immunoregulatory cytokines that are secreted rapidly and differentially. J Leukocyte Biol 2009; 85:117-23.
38. Lee NA, Gelfand EW, Lee JJ. Pulmonary T cells and eosinophils: coconspirators or independent triggers of allergic respiratory pathology? J Allergy Clin Immunol 2001; 107:945-57.
39. Akuthota P,Wang HB, Spencer LA,Weller PF. Immunoregulatory roles of eosinophils: a new look at a familiar cell. Clin Exp Allergy 2008; 38:1254-63.
40. Liu LY, Bates ME, Jarjour NN, Busse WW, Bertics PJ, Kelly EA. Generation of Th1 and Th2 chemokines by human eosinophils: evidence for a critical role of TNF-alpha. J Immunol 2007; 179:4840-8.
41. Padigel UM, Hess JA, Lee JJ et al. Eosinophils act as antigen presenting cells to induce immunity to Strongyloides stercoralis in mice. J Infect Dis 2007; 196:1844-51.
42. Wang H-B, Ghiran I, Matthaei K, Weller PF. Airway eosinophils: allergic inflammation recruited professional antigen-presenting cells. J Immunol 2007; 179:7585-92.
43. Mattes J, Yang M, Mahalingam S et al. Intrinsic defect in T cell production of interleukin (IL)-13 in the absence of both IL-5 and eotaxin precludes the development of eosinophilia and airways hyperreactivity in experimental asthma. J Exp Med 2002; 195:1433-44.
44. Odemuyiwa SO, Ghahary A, Li Y et al. Cutting edge: human eosinophils regulate T cell subset selection through indoleamine 2,3-dioxygenase. J Immunol 2004; 173:5909-13.
45. Minshall EM, Leung DY, Martin RJ et al. Eosinophil-associated TGF-beta1 mRNA expression and airways fibrosis in bronchial asthma. Am J Respir Cell Mol Biol 1997; 17:326-33.
46. Voehringer D, Shinkai K, Locksley RM. Type 2 immunity reflects orchestrated recruitment of cells committed to IL-4 production. Immunity 2004; 20:267-77.
47. Sabin EA, Kopf MA, Pearce EJ. Schistosoma mansoni egg-induced early IL-4 production is dependent upon IL-5 and eosinophils. J Exp Med 1996; 184:1871-78.
48. Rumbley CA, Sugaya H, Zekavat SA, El Refaei M, Perrin PJ, Phillips SM. Activated eosinophils are the major source of Th2-associated cytokines in the schistosome granuloma. J Immunol 1999; 162:1003-9.
49. Jacobsen EA, Ochkur SI, Pero RS et al. Allergic pulmonary inflammation in mice is dependent on eosinophil-induced recruitment of effector T Cells. J Exp Med 2008; 205:699-710.
50. Rothenberg ME, Hogan SP. The eosinophil. Annu Rev Immunol 2006; 24:147-74.
51. Butterfield JH, Ackerman SJ, Scott RE, Pierre RV, Gleich GJ. Evidence for secretion of human eosinophil granule major basic protein and Charcot-Leyden crystal protein during eosinophil maturation. Exp Hematol 1984; 12:163-70.
52. Yen TH, Wright NA. The gastrointestinal tract stem cell niche. Stem Cell Rev 2006; 2:203-12.
53. Kato M, Kephart GM, Morikawa A, Gleich GJ. Eosinophil infiltration and degranulation in normal human tissues: evidence for eosinophil degranulation in normal gastrointestinal tract. Int Arch Allergy Immunol 2001; 125 (Suppl. 1):55-8.
54. Lowichik A, Weinberg AG. A quantitative evaluation of mucosal eosinophils in the pediatric gastrointestinal tract. Mod Pathol 1996; 9:110-4.
55. Zenewicz LA, Antov A, Flavell RA. CD4 T-cell differentiation and inflammatory bowel disease. Trends Mol Med 2009; 15:199-207.
56. Furuta GT, Nieuwenhuis EE, Karhausen J et al. Eosinophils alter colonic epithelial barrier function: role for major basic protein. Am J Physiol Gastrointest Liver Physiol 2005; 289:G890-7.
57. Yousefi S, Gold JA, Andina N et al. Catapult-like release of mitochondrial DNA by eosinophils contributes to antibacterial defense. Nat Med 2008; 14:949-53.
58. Jordan HE, Speidel CC. Blood cell formation and distribution in relation to the mechanism of thyroid-accelerated metamorphosis in the larval frog. J Exp Med 1923; 38:529-41.
59. Throsby M, Herbelin A, Pleau JM, Dardenne M. CD11c+ eosinophils in the murine thymus: developmental regulation and recruitment upon MHC class I-restricted thymocyte deletion. J Immunol 2000; 165:1965-75.
60. Gargett CE, Chan RW, Schwab KE. Hormone and growth factor signaling in endometrial renewal: role of stem/progenitor cells. Mol Cell Endocrinol 2008; 288:22-9.
61. Gouon-Evans V, Pollard JW. Eotaxin is required for eosinophil homing into the stroma of the pubertal and cycling uterus. Endocrinology 2001; 142:4515-21.
62. Blumenthal RD, Samoszuk M, Taylor AP, Brown G, Alisauskas R, Goldenberg DM. Degranulating eosinophils in human endometriosis. Am J Pathol 2000; 156:1581-8.
63. Fabre V, Beiting DP, Bliss SK et al. Eosinophil deficiency compromises parasite survival in chronic nematode infection. J Immunol 2009; 182:1577-83.
64. Stein LH, Redding KM, Lee JJ et al. Eosinophils utilize multiple chemokine receptors for chemotaxis to the parasitic nematode Strongyloides stercoralis. J Innate Immun 2009; 1:618-30.
65. Yang J, Torio A, Donoff RB et al. Depletion of eosinophil infiltration by anti-IL-5 monoclonal antibody (TRFK-5) accelerates open skin wound epithelial closure. Am J Pathol 1997; 151:813-9.
66. Leslie KO, Wick MR. Practical pulmonary pathology - a diagnostic approach. Philadelphia: Churchill Livingstone, 2005.
67. Reutershan J, Ley K. Bench-to-bedside review: acute respiratory distress syndrome - how neutrophils migrate into the lung. Crit Care 2004; 8:453-61.
68. Vignola AM, Chanez P, Chiappara G et al. Evaluation of apoptosis of eosinophils, macrophages, and T lymphocytes in mucosal biopsy specimens of patients with asthma and chronic bronchitis [see comments]. J Allergy Clin Immunol 1999; 103:563-73.
69. Asosingh K, Hanson JD, Cheng G, Aronica M, Erzurum SC. Allergen-induced eotaxin-rich pro-angiogenic bone marrow progenitors a blood borne cellular envoy for lung eosinophilia. J Allergy Clin Immunol 2010, in press.
70. Shen HH, Ochkur SI, McGarry MP et al. A causative relationship exists between eosinophils and the development of allergic pulmonary pathologies in the mouse. J Immunol 2003; 170:3296-305.
71. Polyak K, Weinberg RA. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer 2009; 9:265-73.
72. Lowe D, Jorizzo J, Hutt MS. Tumour-associated eosinophilia: a review. [Review]. J Clin Pathol 1981; 34:1343-8.
73. Protheroe CA, Protheroe C, Woodruff SA et al. A novel histological scoring system to evaluate mucosal biopsies from patients with eosinophilic esophagitis. Clin Gastroenterol Hepatol 2009; 7:749-55.
74. Cormier SA, Taranova AG, Bedient C et al. Pivotal advance: eosinophil infiltration of solid tumors is an early and persistent inflammatory host response. J Leukocyte Biol 2006; 79:1131-9.
75. Gabrilovich DI, Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 2009; 9:162-74.
76. Puxeddu I, Berkman N, Nissim Ben Efraim AH et al. The role of eosinophil major basic protein in angiogenesis. Allergy 2009; 64:368-74.
77. Wong DT, Bowen SM, Elovic A, Gallagher GT, Weller PF. Eosinophil ablation and tumor development. Oral Oncol 1999; 35:496-501.
78. Simson L, Ellyard JI, Dent LA et al. Regulation of carcinogenesis by IL-5 and CCL11: a potential role for eosinophils in tumor immune surveillance. J Immunol 2007; 178:4222-9.
79. Goldman M, Le Moine A, Braun M, Flamand V, Abramowicz D. A role for eosinophils in transplant rejection. Trends Immunol 2001; 22:247-51.
80. Crop MJ, Baan CC, Korevaar SS et al. Donor-derived mesenchymal stem cells suppress alloreactivity of kidney transplant patients. Transplantation 2009; 87:896-906.
81. Simeonovic CJ, Townsend MJ, Karupiah G et al. Analysis of the Th1/Th2 paradigm in transplantation: interferon-gamma deficiency converts Th1-type proislet allograft rejection to a Th2-type xenograft-like response. Cell Transplant 1999; 8:365-73.
82. Hingorani SR, Petricoin EF, Maitra A et al. Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. Cancer Cell 2003; 4:437-50.